A- A A+

Ting-Rong Hsu (許庭榕)

Ting-Rong Hsu(許庭榕)

簡介

學歷
  1. 台北醫學大學 醫學士
  2. 陽明大學臨床醫學研究所 博士
經歷 現職:
  1. - 迄今 台北榮民總醫院兒童醫學部主治醫師
  2. - 迄今 教育部定陽明大學醫學系 助理教授
經歷:
  1. - 台北榮民總醫院兒童醫學部住院醫師
  2. - 台北榮民總醫院兒童神經科臨床研究員
醫療專長
  1. 一般兒科學、預防保健、疫苗接種、發展評估 小兒神經疾病 兒童癲癇 兒童重症醫學 兒童早期療育、發展遲緩 過動、行為問題、頭痛、動作障礙、睡眠問題、神經肌肉疾病
證照
  1. 台灣醫師執照
  2. 台灣醫師執照, 小兒專科醫師 , 小兒神經次專科醫師

著作

1.     Tsai FC, Lee HJ, Wang AG, Hsieh SC, Lu YH, Lee MC, et al. Experiences during newborn screening for glutaric aciduria type 1: Diagnosis, treatment, genotype, phenotype, and outcomes. J Chin Med Assoc. 2017 Apr;80(4):253-61. PubMed PMID: 28302372.

2.     Lu YH, Huang PH, Wang LY, Hsu TR, Li HY, Lee PC, et al. Improvement in the sensitivity of newborn screening for Fabry disease among females through the use of a high-throughput and cost-effective method, DNA mass spectrometry. Journal of human genetics. 2017 Nov 15. PubMed PMID: 29215092.

3.     Liao HC, Hsu TR, Young L, Chiang CC, Huang CK, Liu HC, et al. Functional and biological studies of alpha-galactosidase A variants with uncertain significance from newborn screening in Taiwan. Molecular genetics and metabolism. 2017 Jun 08. PubMed PMID: 28615118.

4.     Lee HJ, Hsu TR, Hung SC, Yu WC, Chu TH, Yang CF, et al. A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation. BMC neurology. 2017 Feb 06;17(1):25. PubMed PMID: 28166746. Pubmed Central PMCID: 5294737.

5.     Hwang HE, Hsu TR, Lee YH, Wang HK, Chiou HJ, Niu DM. Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease. Medicine. 2017 Nov;96(44):e8415. PubMed PMID: 29095275.

6.     Hsu TR, Niu DM. Fabry disease: Review and experience during newborn screening. Trends in cardiovascular medicine. 2017 Oct 20. PubMed PMID: 29100912.

7.     Hsu TR, CHang FP, Chu TH, Sung SH, Bizjajeva S, Yu WC, et al. Correlations between Endomyocardial Biopsies and Cardiac Manifestations in Taiwanese Patients with the Chinese Hotspot IVS4+919G>A Mutation:

Data from the Fabry Outcome Survey. International journal of molecular sciences. 2017;18(1):119.

8.     Auray-Blais C, Lavoie P, Boutin M, Ntwari A, Hsu TR, Huang CK, et al. Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation. Clin Chim Acta. 2017 Jan 17. PubMed PMID: 28108302.

9.     Yang CF, Yang CC, Liao HC, Huang LY, Chiang CC, Ho HC, et al. Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes. The Journal of pediatrics. 2016 Feb;169:174-80 e1. PubMed PMID: 26685070.

10.   Wong TT, Chen HH, Liang ML, Hsieh KL, Yang YS, Ho DM, et al. Clinical considerations and surgical approaches for low-grade gliomas in deep hemispheric locations: thalamic lesions. Childs Nerv Syst. 2016 Oct;32(10):1895-906. PubMed PMID: 27659831.

11.   Lee HJ, Hung SC, Hsu TR, Ko SC, Chui-Mei T, Huang CC, et al. Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation. AJNR Am J Neuroradiol. 2016 Jun;37(6):1044-9. PubMed PMID: 26869469.

12.   Lai CJ, Hsu TR, Yang CF, Chen SJ, Chuang YC, Niu DM. Cognitive Development in Infantile-Onset Pompe Disease Under Very Early Enzyme Replacement Therapy. Journal of child neurology. 2016 Sep 21. PubMed PMID: 27655474.

13.   Hsu TR, Hung SC, Chang FP, Yu WC, Sung SH, Hsu CL, et al. Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation. J Am Coll Cardiol. 2016 Dec 13;68(23):2554-63. PubMed PMID: 27931613.

14.   Yang CF, Yang CC, Liao HC, Huang LY, Chiang CC, Ho HC, et al. Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes. The Journal of pediatrics. 2015 Dec 9. PubMed PMID: 26685070.

15.   Wong TT, Liu YL, Ho DM, Chang KP, Liang ML, Chen HH, et al. Factors affecting survival of medulloblastoma in children: the changing concept of management. Childs Nerv Syst. 2015 Oct;31(10):1687-98. PubMed PMID: 26351222.

16.   Lu YH, Cheng LM, Huang YH, Lo MY, Wu TJ, Lin HY, et al. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency. Clinical nutrition. 2015 Dec;34(6):1155-8. PubMed PMID: 25516282.

17.   Liu HC, Perrin A, Hsu TR, Yang CF, Lin HY, Yu WC, et al. Age at First Cardiac Symptoms in Fabry Disease: Association with a Chinese Hotspot Fabry Mutation (IVS4+919G>A), Classical Fabry Mutations, and Sex in a Taiwanese Population from the Fabry Outcome Survey (FOS). JIMD reports. 2015 Mar 12. PubMed PMID: 25762495.

18.   Lu YH, Cheng LM, Huang YH, Lo MY, Wu TJ, Lin HY, et al. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency. Clinical nutrition. 2014 Dec 3. PubMed PMID: 25516282.

19.   Liu HC, Lin HY, Yang CF, Liao HC, Hsu TR, Lo CW, et al. Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A). Orphanet J Rare Dis. 2014 Jul 22;9(1):111. PubMed PMID: 25047006.

20.   Lin HY, Huang YH, Liao HC, Liu HC, Hsu TR, Shen CI, et al. Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa. J Chin Med Assoc. 2014 Apr;77(4):190-7. PubMed PMID: 24388678.

21.   Hsu TR, Sung SH, Chang FP, Yang CF, Liu HC, Lin HY, et al. Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset fabry mutation (IVS4 + 919G > A). Orphanet J Rare Dis. 2014 Jul 1;9(1):96. PubMed PMID: 24980630.

22.   Chen HH, Chen C, Hung SC, Liang SY, Lin SC, Hsu TR, et al. Cognitive and epilepsy outcomes after epilepsy surgery caused by focal cortical dysplasia in children: early intervention maybe better. Childs Nerv Syst. 2014 Nov;30(11):1885-95. PubMed PMID: 25296550.

23.   Lin HY, Liu HC, Huang YH, Liao HC, Hsu TR, Shen CI, et al. Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A). BMJ open. 2013;3(7). PubMed PMID: 23864212. Pubmed Central PMCID: 3717460.

24.   Liao HC, Huang YH, Chen YJ, Kao SM, Lin HY, Huang CK, et al. Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A). Clin Chim Acta. 2013 Nov 15;426:114-20. PubMed PMID: 24055776.

25.   Chen YW, Huang PI, Ho DM, Hu YW, Chang KP, Chiou SH, et al. Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single institute. Cancer. 2012 May 15;118(10):2752-62. PubMed PMID: 21989828.

26.   Wang CH, Hsu TR, Yang TY, Wong TT, Chang FC, Ho DM, et al. Primary yolk sac tumor of bilateral basal ganglia. J Chin Med Assoc. 2010 Aug;73(8):444-8. PubMed PMID: 20728859. Epub 2010/08/24. eng.

27.   Chiang KL, Chang KP, Lee YY, Huang PI, Hsu TR, Chen YW, et al. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution. Childs Nerv Syst. 2010 Mar 10. PubMed PMID: 20217098. Epub 2010/03/11. Eng.

28.   Wang CH, Hsu TR, Wong TT, Chang KP. Efficacy of temozolomide for recurrent embryonal brain tumors in children. Childs Nerv Syst. 2009 May;25(5):535-41. PubMed PMID: 19107490. Epub 2008/12/25. eng.

29.   Hsu TR, Chang KP, Wong TT. Intracystic Bleomycin Therapy for Craniopharyngioma in Children.

. Neuro-oncology 2009 WFNO abstract. 2009.

30.   Chiang KL, Wong TT, Kwan SY, Hsu TR, Wang CH, Chang KP. Finding on brain MRI mimicking focal cortical dysplasia in early Rasmussen's encephalitis: a case report and review. Childs Nerv Syst. 2009 Nov;25(11):1501-6. PubMed PMID: 19517119. Epub 2009/06/12. eng.

31.   Chiang KL, Chang KP, Wong TT, Hsu TR. Linear scleroderma "en coup de sabre": initial presentation as intractable partial seizures in a child. Pediatr Neonatol. 2009 Dec;50(6):294-8. PubMed PMID: 20025145. Epub 2009/12/23. eng.

32.   Hsu TR, Wong TT, Chang FC, Ho DM, Tang RB, Thien PF, et al. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children. Childs Nerv Syst. 2008 Dec;24(12):1457-61. PubMed PMID: 18769928. Epub 2008/09/05. eng.

33.   Thien PF, Soong WJ, Wang PY, Hsu TR. Harlequin ichthyosis: report of one case. Acta Paediatr Taiwan. 2007 Nov-Dec;48(6):342-4. PubMed PMID: 18437970. Epub 2008/04/29. eng.

34.   Hsu TR, Chen SJ, Wu TC, Chung RL, Tang RB. Tumor necrosis factor-alpha and interleukin-10 in viral and bacterial gastroenteritis in children. J Chin Med Assoc. 2005 Jun;68(6):250-3. PubMed PMID: 15984817. Epub 2005/06/30. eng.